GALT (Galectin Therapeutics) Dividends Received


GALT Galectin Therapeutics Inc GALT
27 GF Score
Price $4.06
! 5 Warning Signs
View Full Analysis

What is Galectin Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

GALT
27GF Score
Galectin Therapeutics Inc GALT
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galectin Therapeutics Business Description

Other Exchanges PHPN:Germany
Address 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
27GF Score

Get the complete analysis for GALT

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.06
Price